Clinical Trials Directory

Trials / Completed

CompletedNCT04995380

Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis (SPRIMACC)

Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis: Protocol for a Prospective Multicenter Observational Study (SPRIMACC)

Status
Completed
Phase
Study type
Observational
Enrollment
1,261 (actual)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The SPRIMACC study is a prospective multicenter observational study with the primary endpoint to prospectively validate the Chole-Risk score in predicting a complicated postoperative course (post-operative major complications (Clavien-Dindo\>=3a), length of stay (LOS) \> 10 days or need of readmission within 30 days from the discharge) in patients undergoing Early Cholecystectomy (EC) for Acute Calculous Cholecystitis (ACC). The secondary endpoints of the study are to prospectively validate and compare other wellknown risk prediction models (the POSSUM/P-POSSUM score, the Modified Frailty Index (mFI), the Charlson Comorbidity Index (CCI), the American Society of Anesthesiologists (ASA) score and the APACHE II score) in predicting a complicated post-operative course in patients undergoing EC.

Conditions

Interventions

TypeNameDescription
PROCEDUREEarly CholecystectomyCholecystectomy performed within 10 days from onset of symptoms

Timeline

Start date
2021-09-01
Primary completion
2022-10-01
Completion
2022-10-01
First posted
2021-08-06
Last updated
2022-12-12

Locations

2 sites across 2 countries: Italy, Spain

Source: ClinicalTrials.gov record NCT04995380. Inclusion in this directory is not an endorsement.